Therapeutic Results of Resection, Transcatheter Arterial Embolization and Percutaneous Transhepatic Ethanol Injection in 3225 Patients With Hepatocellular Carcinoma: A Retrospective Multicenter Study
Munemasa Ryu(Chiba University), M Sugita(Hyogo Medical University), M. Iwasaki(RIKEN), Takayuki Kinoshita(Tokyo National Hospital), Masaru Konishi(Shizuoka Cancer Center), J. Furuse(National Cancer Center Hospital East), N. Moriyama, Masanori Yoshino, N. Kawano(Hokkaido University), Y Shimamura
Cited by 119
Related Papers
Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.
|Proceedings of the National Academy of Sciences|1989|638
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.
|Radiology|1987|352
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients.
|American Journal of Roentgenology|1990|269